chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Heparin-induced thrombocytopenia test positive, Immunoglobulin therapy, Immunology test, Peripheral swelling, Platelet count decreased
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism, Vaccination complication, White blood cell count increased
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Angiogram pulmonary abnormal, Arthralgia, Arthritis bacterial, Blood fibrinogen
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood glucose normal, Brain natriuretic peptide normal, Cellulitis, Chest discomfort, Chills
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Computerised tomogram head normal, Computerised tomogram thorax, Deep vein thrombosis, Erythema
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Feeling hot, Fibrin D dimer, Full blood count abnormal, Gout
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemorrhage intracranial, Headache, Immunology test, International normalised ratio increased, Metabolic function test
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Platelet count decreased, Prothrombin time prolonged, Pulmonary embolism
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Tenderness, Thrombocytopenia, Troponin normal, Ultrasound Doppler abnormal
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Venogram normal, Venous thrombosis
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Blood count, Computerised tomogram head normal, Computerised tomogram thorax abnormal, Deep vein thrombosis
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Fibrin D dimer increased, Headache, Immunoglobulin therapy, Limb discomfort
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling, Pulmonary artery thrombosis, Pulmonary embolism
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Ultrasound Doppler abnormal, Venogram normal
Clinical narrative: Janssen COVID-19 Vaccine EUA: two weeks after vaccination patient reported to an urgent care with right leg swelling and headache. Two days later patient presented an emergency department, diagnosed with left lower extremity deep vein thrombosis (DVT) and bilateral pulmonary emboli (PE). Transferred to current hosptial for management including anticoagulation with a direct thrombin inhibitor, intravenous immune globulin (IVIG), and additional laboratory testing.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood electrolytes normal, Blood fibrinogen normal, Deep vein thrombosis, Electrocardiogram normal
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fibrin D dimer increased, Full blood count, Haematocrit normal, Haemoglobin normal, Headache
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Heparin-induced thrombocytopenia test positive, Immunoglobulin therapy, Immunology test, Peripheral swelling, Platelet count decreased
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism, Vaccination complication, White blood cell count increased
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Angiogram pulmonary abnormal, Arthralgia, Arthritis bacterial, Blood fibrinogen
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood glucose normal, Brain natriuretic peptide normal, Cellulitis, Chest discomfort, Chills
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Computerised tomogram head normal, Computerised tomogram thorax, Deep vein thrombosis, Erythema
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Feeling hot, Fibrin D dimer, Full blood count abnormal, Gout
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemorrhage intracranial, Headache, Immunology test, International normalised ratio increased, Metabolic function test
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Platelet count decreased, Prothrombin time prolonged, Pulmonary embolism
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Tenderness, Thrombocytopenia, Troponin normal, Ultrasound Doppler abnormal
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Venogram normal, Venous thrombosis
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Blood count, Computerised tomogram head normal, Computerised tomogram thorax abnormal, Deep vein thrombosis
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Fibrin D dimer increased, Headache, Immunoglobulin therapy, Limb discomfort
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling, Pulmonary artery thrombosis, Pulmonary embolism
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Ultrasound Doppler abnormal, Venogram normal
Clinical narrative: Per 4/24/21 ED visit MD Note: At the beginning of this week (4/18), he developed some pain in his right posterior thigh, popliteal fossa, and calf. This was short lasting and then appeared on his contralateral side. Over the past few days he has had pain and tenderness over the left calf extending down into the ankle and dorsum of the foot. Now there is some surrounding erythema and warmth as well. No history of cellulitis. No history of gout. No history of DVT or PE. Throughout this course he has had a significant headache which she describes as bitemporal, positional, worse when bent over and better when upright. No photophobia. No altered mental status. No ataxia. No meningismus. Currently the headache is mild to moderate. He was seen at Avon urgent care several days ago and had a negative bilateral lower extremity ultrasound and a noncontrast CT of his head. A CBC demonstrated thrombocytopenia with a platelet count of 25. Over the past few days he has had subjective chills and fatigue. Subjective fever. Subjective body aches. No chest pain or shortness of breath, but he has had have some generalized chest discomfort. This is vague and intermittent. No cough. No other complaint.  His CBC was remarkable for a platelet count of 25. BMP remarkable for a glucose of 138. In regards to today, differential includes cellulitis, DVT, septic joint, gout, headache, dural venous thrombosis, intracranial bleed, PE, amongst other diagnoses. Given his platelet count of 25 and recent Johnson & Johnson administration without risk factors for chronic thrombocytopenia, this is concerning for VITT/VIPIT  Given the above findings, I am worried about VITT/VIPIT in the association with his recent Johnson & Johnson vaccine. Given these concerns, case was discussed with both our hospitalist and the hematology/internal medicine service. At this time, I do recommend transfer given the complicated nature of his syndrome and residual clot burden. No evidence of a submassive pulmonary embolism at this time. Clot burden is moderate.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Fatigue, Feeling abnormal, Laboratory test normal
Clinical narrative: pt says she had violent shaking, like tremors for hours.  She stayed in bed for about 4 days due to the fatigue.  She had brain fog, dizziness and is unbalanced.   She went to her PCP on 3/17/21.  She had blood work with normal results.  These symptoms continued all the way through to her 2nd vaccine.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: pt says she had violent shaking, like tremors for hours.  She stayed in bed for about 4 days due to the fatigue.  She had brain fog, dizziness and is unbalanced.   She went to her PCP on 3/17/21.  She had blood work with normal results.  These symptoms continued all the way through to her 2nd vaccine.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Computerised tomogram thorax normal, Echocardiogram normal, Electrocardiogram normal, Oropharyngeal pain
Clinical narrative: COVID-19 in Nov 2020. At the time had sore throat, runny nose, and body aches for about 3 days. No chest pain at the time.  Patient developed episodic chest pain starting Saturday 4/24 (2 days after vaccination). First episode 4/24 and then again 4/25 PM. Found to have elevated troponins, cardiac imaging normal (EKG, ECHO, chest CT). Depending on trend of troponin may receive IVIG, although currently not indicated given improvement in troponins.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Polymerase chain reaction, Rhinorrhoea, Troponin increased
Clinical narrative: COVID-19 in Nov 2020. At the time had sore throat, runny nose, and body aches for about 3 days. No chest pain at the time.  Patient developed episodic chest pain starting Saturday 4/24 (2 days after vaccination). First episode 4/24 and then again 4/25 PM. Found to have elevated troponins, cardiac imaging normal (EKG, ECHO, chest CT). Depending on trend of troponin may receive IVIG, although currently not indicated given improvement in troponins.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac imaging procedure abnormal, Chest pain, Myocarditis
Clinical narrative: COVID-19 in Nov 2020. At the time had sore throat, runny nose, and body aches for about 3 days. No chest pain at the time.  Patient developed episodic chest pain starting Saturday 4/24 (2 days after vaccination). First episode 4/24 and then again 4/25 PM. Found to have elevated troponins, cardiac imaging normal (EKG, ECHO, chest CT). Depending on trend of troponin may receive IVIG, although currently not indicated given improvement in troponins.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: NONE
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Facial pain, Headache, Hypoaesthesia
Clinical narrative: 4/8 Vaccination  4/14 7:30 in the morning, I was driving my son to school. I got this really bad HA on R side of head. Went away quickly. Left side of face was left numb. I quickly did a neuro check; I could move fingers, eyes, etc. I called nurse and told to go to the ER.  At the ER, Covid test; neg, CT scan, MRI, blood work; all normal. Something happened to the nerve on that side of my face, trigeminal nerve.  It took a couple days for the numbness to dissipate. But I do still have some pain on the L side of my face.  Told to follow up with PCM; scheduled for 429/2021
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, SARS-CoV-2 test negative, Trigeminal nerve disorder
Clinical narrative: 4/8 Vaccination  4/14 7:30 in the morning, I was driving my son to school. I got this really bad HA on R side of head. Went away quickly. Left side of face was left numb. I quickly did a neuro check; I could move fingers, eyes, etc. I called nurse and told to go to the ER.  At the ER, Covid test; neg, CT scan, MRI, blood work; all normal. Something happened to the nerve on that side of my face, trigeminal nerve.  It took a couple days for the numbness to dissipate. But I do still have some pain on the L side of my face.  Told to follow up with PCM; scheduled for 429/2021